Background Investigation Methods, Corporate Intelligence & Due Diligence, e-Discovery Techniques, Investigation & Intelligence Feeds, Judgment Enforcement, Legal Enforcement Cases, Legal Ethics & Intelligence, Legal Technology & Intelligence, Witness Credibility Analysis

DEA signals extension of telemedicine flexibilities for controlled substance prescribing for 2026

Posted by author-avatar
0
Test Logo Transparent

A new rule posted on the Office of Management and Budget (OMB) registry suggests that the US Drug Enforcement Administration (DEA) is planning an additional extension of COVID-19-era flexibilities for telemedicine prescribing of controlled substances beyond the current expiration date of December 31, 2025….
By: McDermott Will & Schulte

Newer
INTERNAL DNC RULES STAND: FCC Amends Adopted NPRM To Clarify Internal DNC Rules Are Not On the Chopping Block
Back to list
Older It Is Not Only Alright To Shame, And Ultimately Ostracize, Your MAGA Relatives, It Is Your Patriotic Duty As An American

Leave a Reply

Your email address will not be published. Required fields are marked *